January 12, 2013 article Open access Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial Blood DOI: 10.1182/blood-2012-07-443770 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 3 stored of 332 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options 2024 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access 16 citations Unmet clinical needs in the management of CALR-mutated essential thrombocythaemia: a consensus-based proposal from the European LeukemiaNet 2021 The Lancet Haematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment 30 citations The Approach to Thrombosis Prevention across the Spectrum of Philadelphia-Negative Classic Myeloproliferative Neoplasms 2021 Hemato article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access 2 citations 3 results References 0